Hospital Israelita Albert Einstein Selects Cerner

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Hospital Israelita Albert Einstein Selects Cerner Millennium(R) Solutions to Streamline Operations

KANSAS CITY, Mo., Oct. 8, 2013 (GLOBE NEWSWIRE) -- Hospital Israelita Albert Einstein, a private, 674-bed hospital with eight ambulatory clinics in São Paulo, will be the first in Brazil to implement Cerner Millennium ® health care information technology (HIT) solutions. The technology will help streamline operations in multiple areas of the hospital, while improving care for all patients.

Hospital Israelita Albert Einstein was the first in Latin America to receive international accreditation from the Joint Commission International.

"Albert Einstein hospital is extremely progressive in terms of quality and technology, and we look for the same characteristics in our suppliers and partners," said Dr. Claudio Lottenberg, President of Hospital Israelita Albert Einstein. "Our clinical activity is centered on the patient. By introducing Cerner's integrated technology, we will be able to deliver efficient care and increase patient safety."

With the implementation at Hospital Israelita Albert Einstein, Cerner will have clients in 24 countries. Albert Einstein will be the first client to leverage Cerner Millennium in Portuguese.

"We are excited to announce our entry into the Brazilian health IT market with this preeminent hospital," said Neal Patterson, co-founder, chairman and CEO of Cerner. "For more than three decades, Cerner has been addressing important challenges in health care with technology, knowledge and content, working with clients in 24 countries to improve efficiency, reduce costs and elevate the standard of care. It will be rewarding to partner with Hospital Israelita Albert Einstein to deploy all of our solutions for improving the health of populations. Together with Einstein, we share a mission of advancing excellence in health care and enhancing the quality of life for people and communities."

The first phase of the project will include: translation of Millennium into Portuguese, Orders, Documentation, electronic medical record (EMR), Pharmacy, Patient Management, Billing, ER, ICU, Oncology, Cardiology, Laboratory, Surgery, Ambulatory process, Medication Administration, Women's Health and various Performance Improvement and Quality Outcomes solutions among others across the main acute care facility and clinics. This project demonstrates the flexibility of the Cerner Millennium architecture to meet the language and workflow requirements of those in different countries around the world.

About Cerner

Cerner is contributing to the systemic change of health and care delivery. For more than 30 years Cerner has been executing its vision to make health care safer and more efficient. We started with the foundation of digitizing paper processes and now offer the most comprehensive array of information software, professional services, medical device integration, remote hosting and employer health and wellness services. Cerner systems are used by everyone from individual consumers, to single-doctor practices, hospitals, employers and entire countries. Taking what we've learned over more than three decades, Cerner is building on the knowledge that is in the system to support evidence-based clinical decisions, prevent medical errors and empower patients in their care.

Cerner® solutions are licensed by approximately 10,000 facilities around the world, including more than 2,700 hospitals; 4,150 physician practices; 45,000 physicians; 550 ambulatory facilities, such as laboratories, ambulatory centers, behavioral health centers, cardiac facilities, radiology clinics and surgery centers; 800 home health facilities; 45 employer sites and 1,750 retail pharmacies.

Certain trademarks, service marks and logos (collectively, the "Marks") set forth herein are owned by Cerner Corporation and/or its subsidiaries in the United States and certain other countries throughout the world. All other non-Cerner Marks are the property of their respective owners. Nasdaq: CERN. For more information about Cerner, please visit www.cerner.com , Twitter , Facebook  and YouTube .

Cerner Media Contact: Megan Moriarty, (816) 888-2470, megan.moriarty@cerner.com

Cerner Investors Contact: Allan Kells, (816) 201-2445, akells@cerner.com          

About Sociedade Beneficente Israelita Brasileira Albert Einstein (SBIBAE)

The SBIBAE operates in three integrated and equally important fronts: health care, social responsibility and the generation and dissemination of knowledge. The activities of health care are concentrated in the Hospital Israelita Albert Einstein and in the area of ​​preventive and diagnostic medicine, that contribute to the sustainability of social responsibility, teaching and research. The Instituto Israelita Albert Einstein de Responsabilidade Social (IIRS) works in its own programs or in conjunction with public health system to help meet the health care needs, or technological skills of the community. The research and education activities are housed in the Instituto Israelita de Ensino e Pesquisa (IIEP) and confer innovation to other areas of SBIBAE.

Hospital Israelita Albert Einstein Media Contact:

Mirtes Bogéa (55.02111.2151-0349) mirtes.bogea@einstein.br

Camila Abranches (55-02111-2151-0464) camila.abranches@einstein.br

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Capricor's Challenges: FDA Review Delays and Legal Woes

Updated Category News Views 21

Capricor Under the Spotlight: FDA and SEC Concerns Ah, Capricor Therapeutics, Inc. (NASDAQ: CAPR)—a tale of high stakes and even higher expectations now hanging by a very taut thread. Investors are feeling the heat as the U.S. Food and Drug Administration (FDA) presses pause on Capricor's plans, and the courtroom drama unfolds with a securities class action looming over...

Continue Reading
La Rosa Holdings Achieves Record Growth with 188% Revenue Surge

Updated Category News Views 144

La Rosa Holdings Reports Impressive Revenue Growth in 2024 Revenue for Q3 2024 Climbs 188% Year-Over-Year to $19.6 Million Aiming for $100 Million in Annualized Revenue by Year-End La Rosa Holdings Corp. (NASDAQ: LRHC) recently disclosed its financial progress, showcasing remarkable growth in the real estate sector. The company revealed that its total revenue witnessed a...

Continue Reading
Navigating the Intricacies of Micron Technology's Options Market

Updated Category News Views 163

Understanding Micron Technology's Market Landscape Investors have recently adopted a bearish stance towards Micron Technology (NASDAQ: MU), a trend that calls for attention among market participants. The sizable options activities we've noticed could hint at significant changes brewing in the market for this semiconductor giant. These insights stem from a comprehensive...

Continue Reading
Viz.ai Unveils New Data Showcasing Stroke Treatment Innovations

Updated Category News Views 288

Viz.ai is cutting through the noise in stroke treatment with its revolutionary technology. They’ve recently unveiled some pretty remarkable clinical data showcasing how their product, Viz LVO, can significantly alter the game for patients dealing with large vessel occlusions—an ischemic stroke that typically spells trouble. This isn’t just another tech story; it’s...

Continue Reading
Linda A. Smith: A Leader in Finance and Budgeting

Updated Category News Views 170

Linda A. Smith Earned Pinnacle Professional Membership Linda A. Smith has made a remarkable mark in the finance sector, and her recent accolade as a Pinnacle Professional Member is a testament to her expertise and commitment. With more than 23 years of experience in finance and budgeting, she brings an impressive array of knowledge and skills to her role. Distinguished...

Continue Reading